For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Novartis Finance Corporation

Calculating rank

USPTO Granted Patents = 126

% Expired Patents = 0.79

Trademarks = 1

Forward Citations = 2,041

Loading Chart...

Loading Chart...

196 inventors (with patents filed for the assignee):

John A Ryals (21 out of 35 patents)

Michael G Koziel (16 out of 71 patents)

Eric R Ward (15 out of 25 patents)

4. Nalini M Desai (14 out of 37 patents)

5. Gregory W Warren (14 out of 31 patents)

6. Stephen T Lam (11 out of 18 patents)

7. Scott Joseph Uknes (9 out of 37 patents)

8. Dwight Steven Hill (9 out of 13 patents)

9. James Joseph Beck (9 out of 14 patents)

10. Gordon J Nye (9 out of 11 patents)

11. Juan J Estruch (8 out of 11 patents)

12. Martha A Mullins (8 out of 9 patents)

13. Brian S Carr (7 out of 81 patents)

14. Sandra L Volrath (7 out of 15 patents)

15. Kristy Kostichka (7 out of 8 patents)

Core Competencies:

Herbicide Tolerance

Insect Resistance

Genetic Transformation

Pesticidal Proteins

DNA Sequences

Crop Protection

Mutant Plants

Transgenic Plants

Plant Cells

Polypeptides

Disease Resistance

Signal Transduction

126 patents: Sort by Forward Citations

1. 6632981 - DNA sequences encoding polypeptides having beta-1,3-glucanase activity (2003-10-14),

2. 6410329 - Method for achieving site specific integration of exogenous DNA delivered by non-biological means to plant cells (2002-06-25),

3. 6308458 - Herbicide-tolerant plants and methods of controlling the growth of undesired vegetation (2001-10-30),

4. 6300519 - Antivirally active heterocyclic azahexane derivatives (2001-10-09),

5. 6282837 - Methods of controlling the growth of undesired vegetation with herbicide tolerant plants or plant seeds having altered protoporphyrinogen oxidase activity (2001-09-04),

6. 6262342 - DNA sequences encoding polypeptides having &bgr;-1,3-glucanase activity (2001-07-17),

7. 6232525 - Mutant plants and uses therefor (2001-05-15),

8. 6201169 - Transformation of hereditary material of Brassica plants and cells (2001-03-13),

9. 6177245 - Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms (2001-01-23),

10. 6166004 - Combinations of HIV protease inhibitors with reverse transcriptase (2000-12-26),

11. 6153374 - Method for identifying inhibitors of soraphen A resistant (2000-11-28),

12. 6150585 - Nucleic acids encoding tospovirus genome and expression thereof (2000-11-21),

13. 6147282 - Method of controlling the fertility of a plant (2000-11-14),

14. 6137033 - Class of proteins for the control of plant pests (2000-10-24),

15. 6133417 - Cytochrome P-450 monooxygenases (2000-10-17),

Company Overview

Novartis Finance Corporation, based in New York, specializes in plant biotechnology, focusing on advancements that enhance agricultural productivity and sustainability. The organization is engaged in the development of innovative solutions such as herbicide tolerance and insect resistance, utilizing genetic transformation techniques. Their research encompasses a range of core technology topics, including the creation of transgenic plants and the application of pesticidal proteins, aimed at improving crop protection and yield in diverse agricultural settings.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

126 Patents

#94 in New York, NY

#194 in New York

#3,086 in US

#6,375 in the World

New York, NY, United States of America

Novartis Finance Corporation

Forward Citations = 2,041

196 inventors:

John A Ryals (21 out of 35 patents)

Michael G Koziel (16 out of 71 patents)

Eric R Ward (15 out of 25 patents)

4. Nalini M Desai (14 out of 37 patents)

5. Gregory W Warren (14 out of 31 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novartis Finance Corporation. Retrieved from https://idiyas.com/company/novartis-finance

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…